Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Elan establishes new agreement with Wyeth-Ayerst for integrin inhibitors

Feb. 3, 2000

Patent applications filed by IGT for neuropharmaceuticals

Feb. 2, 2000

New patents cover significant improvements to Avigen's AAV vector technology

Feb. 1, 2000

Immtech dication compounds show potential as small-molecule regulators of gene function

Jan. 31, 2000

Newly issued U.S. patent protects Inhale's dry powder DNA formulations

Jan. 28, 2000

Synaptic and Kissei enter genomics research collaboration

Jan. 26, 2000

DepoMed and Elan finalize joint venture agreements

Jan. 25, 2000

Pharmacopeia and Organon collaborate on IL-8 research

Jan. 25, 2000

NIH and DuPont establish OncoMouse technology agreement

Jan. 25, 2000

SB-269970: a potent and selective 5-HT7 receptor antagonist ligand

Jan. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...